An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic LeukemiaTanja A. Grüber, James R. Downing, Amanda Larson Gedman et al.|Cancer Cell|2012Cited by 276
Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat lineShuqing Lü, Jianmin Wang, Zhilong Chen et al.|Experimental Hematology|2008Cited by 89
Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell lineShuqing Lü, Jianmin Wang, Jianmin Yang et al.|Experimental Hematology|2009Cited by 84
Allogeneic Peripheral Blood Stem Cell Transplantation is a Promising and Safe Choice for the Treatment of Refractory/Relapsed Acute Myelogenous Leukemia, Even with a Higher Leukemia BurdenWeiping Zhang, Jianmin Wang, Dan Yang et al.|Biology of Blood and Marrow Transplantation|2013Cited by 39
A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from ChinaJianmin Wang, Weiping Zhang, Shuqing Lü et al.|Journal of Hematology & Oncology|2009Cited by 36